These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38853507)

  • 21. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
    Brás IC; Outeiro TF
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-Synuclein seed amplification technology for Parkinson's disease and related synucleinopathies.
    Soto C
    Trends Biotechnol; 2024 Jul; 42(7):829-841. PubMed ID: 38395703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission.
    Imamura Y; Okuzumi A; Yoshinaga S; Hiyama A; Furukawa Y; Miyasaka T; Hattori N; Nukina N
    Commun Biol; 2022 Jun; 5(1):636. PubMed ID: 35768587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of synucleinopathic seeding by rationally designed inhibitors.
    Sangwan S; Sahay S; Murray KA; Morgan S; Guenther EL; Jiang L; Williams CK; Vinters HV; Goedert M; Eisenberg DS
    Elife; 2020 Jan; 9():. PubMed ID: 31895037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.
    Bae EJ; Yang NY; Song M; Lee CS; Lee JS; Jung BC; Lee HJ; Kim S; Masliah E; Sardi SP; Lee SJ
    Nat Commun; 2014 Aug; 5():4755. PubMed ID: 25156829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein.
    Zhang S; Zhu R; Pan B; Xu H; Olufemi MF; Gathagan RJ; Li Y; Zhang L; Zhang J; Xiang W; Kagan EM; Cao X; Yuan C; Kim SJ; Williams CK; Magaki S; Vinters HV; Lashuel HA; Garcia BA; James Petersson E; Trojanowski JQ; Lee VM; Peng C
    Nat Neurosci; 2023 Feb; 26(2):213-225. PubMed ID: 36690898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies.
    Marvian AT; Koss DJ; Aliakbari F; Morshedi D; Outeiro TF
    J Neurochem; 2019 Sep; 150(5):535-565. PubMed ID: 31004503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats.
    Van Den Berge N; Ferreira N; Mikkelsen TW; Alstrup AKO; Tamgüney G; Karlsson P; Terkelsen AJ; Nyengaard JR; Jensen PH; Borghammer P
    Brain; 2021 Jul; 144(6):1853-1868. PubMed ID: 33880502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson's Disease.
    Battis K; Xiang W; Winkler J
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Synuclein in synaptic function and dysfunction.
    Sharma M; Burré J
    Trends Neurosci; 2023 Feb; 46(2):153-166. PubMed ID: 36567199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils.
    Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P
    J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein.
    Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR
    Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease.
    Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z
    Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
    Gupta V; Salim S; Hmila I; Vaikath NN; Sudhakaran IP; Ghanem SS; Majbour NK; Abdulla SA; Emara MM; Abdesselem HB; Lukacsovich T; Erskine D; El-Agnaf OMA
    Sci Rep; 2020 May; 10(1):8137. PubMed ID: 32424162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-Synuclein and Lipids: The Elephant in the Room?
    Sarchione A; Marchand A; Taymans JM; Chartier-Harlin MC
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
    Luna E; Luk KC
    FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts.
    Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M
    Nat Commun; 2019 Dec; 10(1):5535. PubMed ID: 31797870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies.
    Chopra A; Outeiro TF
    Brain; 2024 Jan; 147(1):81-90. PubMed ID: 37526295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.